Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer

Gilcrease, GW; Stenehjem, DD; Wade, ML; Weis, J; McGregor, K; Whisenant, J; Boucher, KM; Thorne, K; Orgain, N; Garrido-Laguna, I; Sharma, S

Gilcrease, GW (reprint author), Univ Utah, Dept Internal Med, Huntsman Canc Inst, Div Oncogen, Salt Lake City, UT 84112 USA.

INVESTIGATIONAL NEW DRUGS, 2019; 37 (3): 482

Abstract

Background This phase I/II trial evaluated toxicity and antitumor activity of everolimus plus mFOLFOX6+bevacizumab for first-line treatment of metasta......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索